Viking Therapeutics, Inc VKTX
$28.99
-1.26%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-534,796,000
- Net Margin
- —
- Return on Equity
- -130.98%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 8.28
- Price / Sales
- —
Over the trailing twelve months, Viking Therapeutics, Inc generated revenue of — and net income of $-534,796,000.
Key Stats
- Last Close
- $28.99
- Market Cap
- $3.38 billion
- 52-Week Range
- $22.96 – $43.15
- Average Volume
- 1.89 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.